BriaCell Therapeutics BCTX
NASDAQ BCTX
$3.60 +0.14 (+4.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Receivables - Other (2022 - 2025)

Updated

BriaCell Therapeutics (BCTX) posted Receivables - Other of $119,009 for fiscal Q4 2025 (quarter ended Jul 31, 2025), down 74.9% from $473,330 a year earlier.

Analysis

BriaCell Therapeutics (BCTX) Receivables - Other (2022 - 2025) Analysis & Trends

Since fiscal Q4 2022, BriaCell Therapeutics has reported Receivables - Other for 4 quarters.

  • Annual Receivables - Other shows a three-year compound annual growth rate of 16.4% (FY2022 to FY2025).
  • In prior fiscal years, BriaCell Therapeutics' Receivables - Other was $473,330 in FY2024, $40,753 in FY2023 (-46.1%) and $75,558 in FY2022.
  • The fiscal Q4 2025 figure stands as the lowest quarterly Receivables - Other since fiscal Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 BriaCell Therapeutics 25.67 Mn -55.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2025 119,009.00
Jul 31, 2024 473,330.00
Jul 31, 2023 40,753.00
Jul 31, 2022 75,558.00
API Access

BriaCell Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=BCTX&period=max&api_key=YOUR_API_KEY